- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01749020
Effect of Polyphenol-rich Dark Chocolate on Insulin Sensitivity in Normal Weight and Overweight Adults
November 19, 2013 updated by: Grace Farhat, Queen Margaret University
The purpose of the study is to determine the effect of polyphenol-rich dark chocolate on insulin sensitivity in normal weight and overweight adults.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Polyphenols may have several favourable effects on health.
Dark chocolate (DC) is one of the highest sources of polyphenols in foods.
The aim of the study is to determine the effect of polyphenol-rich dark chocolate on insulin sensitivity in normal weight and overweight adults.
Seventy four volunteers with no history of hypertension, cardiovascular diseases or diabetes will be recruited.
Participants will randomly receive 20g daily of one of the two different types of DC: Placebo DC (low in polyphenols) or DC rich in polyphenols (500mg) for a period of four weeks.
Participants will be asked to make two appointments to the university clinical lab.
Anthropometric measurements (height, weight, waist circumference), blood and saliva samples will be taken during each of the 2 visits.
Compliance will be tested by the measure of total polyphenols in a 24-hour urine sample in some random samples before and at the end of the intervention.
To monitor any fluctuations in the participants' diet or physical activity during the study period, a three-day diet diary and a physical activity questionnaire will be collected before the start of the study and after four weeks.
Data will be analysed with an ANCOVA with time (pre- and post-) and treatment (DC and placebo) as between-subject factor.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
East Lothian
-
Musselburgh, East Lothian, United Kingdom, EH21 6UU
- Queen Margaret University Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults with no history of hypertension, diabetes and cardiovascular diseases
- BMI from 18-24.9 and BMI >25
- Males and Females
- Age: 18-65 years
Exclusion Criteria:
- Participants with cardiovascular diseases, hypertension or diabetes
- Smokers and heavy alcohol drinkers
- Participants taking any medications that affect insulin, cholesterol, triglycerides or blood pressure
- Participants taking dietary supplements containing high doses of antioxidants
- Postmenopausal women taking HRT (Hormone Replacement Therapy)
- Participants who recently participated or are currently on a weight management program
- Participants with regular consumption of cocoa or DC (> 1 serving/week)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Polyphenol-rich Dark chocolate
Dark chocolate with 500 mg of polyphenols
|
Participants will be asked to consume 20g of dark chocolate containing 500mg of polyphenols daily for a period of 4 weeks
|
Placebo Comparator: Placebo Dark chocolate
This chocolate contains little or no polyphenols
|
Participants will be asked to consume 20g of dark chocolate containing little or no polyphenols for a period of 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determine if the consumption of DC rich in polyphenols can induce a change in insulin sensitivity
Time Frame: Baseline and week 4
|
Insulin sensitivity will be determined by determined by HOMA-IR (Homeostasis Model of Assessment - Insulin Resistance)
|
Baseline and week 4
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Determine if the consumption of DC rich in polyphenols can induce a change in glucose levels
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in Lipid profile (TC, HDL, LDL & TG)
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in oxidized LDL levels
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in BMI and Waist circumference
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in blood pressure
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in salivary cortisol-to-cortisone ratio
Time Frame: Baseline and week 4
|
Baseline and week 4
|
Determine if the consumption of DC rich in polyphenols can induce a change in high sensitivity CRP
Time Frame: Baseline and Week 4
|
Baseline and Week 4
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Emad Al-Dujaili, PhD, Queen Margaret University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2012
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
December 10, 2012
First Submitted That Met QC Criteria
December 12, 2012
First Posted (Estimate)
December 13, 2012
Study Record Updates
Last Update Posted (Estimate)
November 20, 2013
Last Update Submitted That Met QC Criteria
November 19, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DC-Ins01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Assiut UniversityCompleted
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
-
The University of Texas Medical Branch, GalvestonCompletedInsulin Resistance, DiabetesUnited States
-
University Health Network, TorontoCompletedInsulin Resistance, DiabetesCanada
Clinical Trials on Polyphenol-rich Dark chocolate
-
Queen Margaret UniversityBarry CallebautCompletedBody WeightUnited Kingdom
-
Queen Margaret UniversityUnknown
-
Technological Centre of Nutrition and Health, SpainCompletedGene Expression | Cardiovascular FunctionSpain
-
Queen Margaret UniversityCompleted
-
Laval UniversityCompleted
-
Loma Linda UniversityCompleted
-
Laval UniversityCompleted
-
Universidad de AntioquiaTerminated
-
University of Roma La SapienzaCompleted